SCHEMBL4078192

SCHEMBL4078192

CC(C)C(=O)CNC(=O)CCNC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 3/20 0.38
RECQL P46063 1/20 0.34
GAA P10253 1/20 0.34
ECE1 P42892 4/20 0.33
FAAH O00519 4/20 0.33
PSMB5 P28074 2/20 0.32
CNR1 P21554 2/20 0.31
CNR2 P34972 2/20 0.31
LMNA P02545 2/20 0.31
PKM P14618 1/20 0.31
NAMPT P43490 1/20 0.31
MAPT P10636 1/20 0.31
PTGS2 P35354 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20017058 0.83 ALDH1A1 (0.41) CYP2D6CYP2C19ALDH1A1RECQLGAA
SCHEMBL25173385 0.81 CYP2D6 (0.46) CYP2D6CYP2C19ALDH1A1ECE1LMNA
SCHEMBL10140886 0.81 CYP2D6 (0.50) CYP2D6CYP2C19ALDH1A1ECE1LMNA
SCHEMBL25132447 0.80 ALDH1A1 (0.39) ALDH1A1RECQLCNR1NAMPT
SCHEMBL18513247 0.79 ALDH1A1 (0.39) CYP2D6CYP2C19ALDH1A1RECQLGAA
SCHEMBL18513246 0.79 RECQL (0.54) ALDH1A1RECQLGAAFAAHPSMB5
SCHEMBL13197236 0.79 RECQL (0.48) ALDH1A1RECQLGAAFAAHPSMB5
SCHEMBL29329056 0.78 ECE1 (0.39) ALDH1A1RECQLECE1CNR1LMNA
SCHEMBL14113354 0.76 ALDH1A1 (0.42) ALDH1A1RECQLGAAFAAHPSMB5
SCHEMBL27312240 0.76 ALDH1A1 (0.45) CYP2D6CYP2C19ALDH1A1RECQLGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354418-B2 Thiazolyl-dihydro-quinazolines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-15 US disclosed
US-20090131424-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-05-21 US disclosed
US-7517995-B2 Thiazolyl-dihydro-cyclopentapyrazole BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-14 US disclosed
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE ROR1, RORB, RORA CYP2D6 30/4885CYP2C19 85/4885ALDH1A1 60/4885
US-20090131424-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE CYP3A7, UGT2B7, UGT1A7 CYP2D6 50/4885CYP2C19 204/4885ALDH1A1 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.